Profile data is unavailable for this security.
About the company
Zenith Drugs Ltd is an India-based pharmaceutical manufacturing and trading company. The Company manufactures and trades pharmaceuticals, drugs enzymes and sanitary napkins and all classes of chemicals used for manufacture of the aforesaid and all other kinds of chemicals and their by-products intermediates, derivatives, formulations, and compounds. It offers a range of formulations in various forms, such as ORS powder, liquid orals, ointments, liquid externals, and capsules. Its liquid orals products include Iron & Folic Acid Syrup IP, Hungrykop Syrup, BIozen Multivitamin Syrup, Rexkop DX Syrup, and Zoomol Plus Syrup. Its ointment products include Clobetol GM Cream, Painfree Gel, POVIZ M Ointment, and Candizen Cream. Its liquid external section products include Poviz Solutin (Lotion), Bioscaby Lotion, Permethirn Lotion, Gamma Benzene Hexachloride 1% Lotion, and Scabikop Lotion. Its capsule section products include Pyvoxee Spas Plus Capsule, BIO-Omi Capsule, and Lopagen Capsule.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2000
- Employees--
- LocationZenith Drugs LtdDepalpurNa, Village Muradpura, K. No. 72/5INDORE 453001IndiaIND
- Websitehttp://www.zenithdrugs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofil Chemicals and Pharmaceuticals Ltd | 384.48m | 6.69m | 1.02bn | -- | 151.88 | -- | 92.59 | 2.65 | 0.4118 | 0.4118 | 23.91 | -- | -- | -- | -- | -- | -- | 2.86 | -- | 5.39 | 6.82 | 11.61 | 1.74 | 2.97 | -- | 27.03 | -- | -- | 34.19 | 19.43 | -19.76 | 3.55 | -51.09 | -- |
| Lasa Supergenerics Ltd | 1.04bn | -217.31m | 1.06bn | 89.00 | -- | 1.10 | -- | 1.02 | -4.33 | -4.33 | 20.80 | 19.30 | 0.663 | 4.57 | 34.41 | -- | -13.81 | -3.86 | -19.48 | -5.34 | 27.91 | 33.50 | -20.83 | -5.30 | 0.3856 | -4.40 | 0.1859 | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
| Zenith Drugs Ltd | -100.00bn | -100.00bn | 1.09bn | -- | -- | 4.83 | -- | -- | -- | -- | -- | 13.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8679 | -- | 0.5617 | -- | 24.95 | -- | 64.70 | -- | -- | -- |
| Ind Swift Ltd | 5.02bn | 142.31m | 1.17bn | 1.67k | 8.21 | -- | 2.83 | 0.2329 | 2.63 | 2.63 | 92.94 | -127.54 | 0.7705 | 3.66 | 3.91 | -- | 2.18 | -0.902 | 60.58 | -- | 44.02 | 45.72 | 2.83 | -1.44 | 0.8668 | 0.3401 | 3.14 | -- | 22.21 | 11.68 | -45.34 | 11.68 | 15.24 | -- |
| Sotac Pharmaceuticals Ltd | 579.83m | 44.96m | 1.27bn | 89.00 | 20.61 | 8.04 | 20.76 | 2.19 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| Aarey Drugs and Pharmaceuticals Ltd | 3.48bn | 42.19m | 1.29bn | 0.00 | 27.58 | -- | 22.50 | 0.3695 | 1.66 | 1.66 | 137.72 | -- | -- | -- | -- | -- | -- | 2.78 | -- | 5.84 | 4.17 | 3.66 | 1.21 | 1.52 | -- | 1.63 | -- | -- | -14.96 | 3.70 | -42.38 | -9.40 | 10.95 | -- |
| Krebs Biochemicals And Industries Ltd | 504.22m | -197.29m | 1.34bn | 210.00 | -- | -- | -- | 2.65 | -9.16 | -9.16 | 23.41 | -55.29 | 0.2856 | 0.606 | 41.52 | -- | -11.17 | -17.87 | -16.29 | -27.01 | 86.94 | 24.50 | -39.13 | -58.62 | 0.1237 | -3.30 | 2.61 | -- | -3.29 | 1.09 | 20.10 | -- | 16.76 | -- |
